Cardiac Effects of Anti-viral drugs in Chronic Hepatitis C Egyptian Patients

Abstract

o this day, hepatitis C virus infection represents a global burden. The long term impact of HCV infection is highly variable, ranging from minimal effects to severe extra-hepatic complications. The goal of therapy is to eradicate HCV and in light of the advances in HCV therapy and treatment, monitoring is required to ensure broad access to these new therapies. The aim of this study is to investigate possible cardiac effects of direct antiviral drugs “sofosbuvir & daclatasvir” on Egyptian HCV patients.